Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/vaccines8040566 http://scihub22266oqcxt.onion/10.3390/vaccines8040566 33019507!7712378!33019507     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33019507&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Vaccines+(Basel) 2020 ; 8 (4): ? Nephropedia Template TP {{tp|p=33019507|t=2020. Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines |pdf=|usr=}}{{33019507}} gab.com Text Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines JO: Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33019507 #FOAvip Rapid obtaining of safe, effective, anti-viral vaccines has recently risen to the top of the international agenda. To maximize the success probability of future anti-viral vaccines, the anti-viral vaccines successful in the past are summarized here by virus type and vaccine type. The primary focus is on viruses with both single-stranded RNA genomes and a membrane envelope, given the pandemic past of influenza viruses and coronaviruses. The following conclusion is reached, assuming that success of future strategies is positively correlated with strategies successful in the past. The primary strategy, especially for emerging pandemic viruses, should be development of vaccine antigens that are live-attenuated viruses; the secondary strategy should be development of vaccine antigens that are inactivated virus particles. Support for this conclusion comes from the complexity of immune systems. These conclusions imply the need for a revision in current strategic planning. Twit Text FOAVip Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines ????Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33019507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33019507 #FOAvip English Wikipedia <ref>{{Cite pmid|33019507}}</ref> Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines #MMPMID33019507 Serwer P Vaccines (Basel) 2020[Oct]; 8 (4): ? PMID33019507show ga Rapid obtaining of safe, effective, anti-viral vaccines has recently risen to the top of the international agenda. To maximize the success probability of future anti-viral vaccines, the anti-viral vaccines successful in the past are summarized here by virus type and vaccine type. The primary focus is on viruses with both single-stranded RNA genomes and a membrane envelope, given the pandemic past of influenza viruses and coronaviruses. The following conclusion is reached, assuming that success of future strategies is positively correlated with strategies successful in the past. The primary strategy, especially for emerging pandemic viruses, should be development of vaccine antigens that are live-attenuated viruses; the secondary strategy should be development of vaccine antigens that are inactivated virus particles. Support for this conclusion comes from the complexity of immune systems. These conclusions imply the need for a revision in current strategic planning. ?Using the Past to Maximize the Success Probability of Future Anti-Vira(epmc).pdf DeepDyve Pubget Overpricing